August 9, 2012
Astellas Pharma announced on August 8 that it submitted an application on the same day to the Ministry of Health, Labor and Welfare (MHLW) for an orally disintegrating (OD) tablet of Irribow (ramosetron) for diarrhea-predominant irritable bowel syndrome (IBS) in...read more